Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Medibank Private ( (AU:MPL) ) has issued an update.
Medibank Private Limited has announced the appointment of Jacqueline Hey and Dr. Lisa McIntyre as non-executive directors, effective from November 19, 2025. This strategic addition to the board is expected to enhance the company’s governance and potentially strengthen its market position, reflecting Medibank’s commitment to robust leadership and strategic oversight.
The most recent analyst rating on (AU:MPL) stock is a Buy with a A$5.84 price target. To see the full list of analyst forecasts on Medibank Private stock, see the AU:MPL Stock Forecast page.
More about Medibank Private
Medibank Private Limited is a prominent player in the health insurance industry, offering a range of health insurance products and services. The company focuses on providing comprehensive health coverage and related services to its customers, positioning itself as a leader in the Australian health insurance market.
Average Trading Volume: 5,882,641
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$13.38B
See more data about MPL stock on TipRanks’ Stock Analysis page.